Automated system for precise quantification of cell-free DNA in blood samples as part of liquid biopsy analysis. Measures both normal cfDNA and tumor-derived ctDNA to assess cancer burden and genetic changes.
Manufactured by
Biopsense Oy
Jyvaskyla, Finland
BiopSense is developing a fully automated blood processing solution to help health care professionals, such as laboratories to solve the current complicated biopsy workflows with our unique cartridge technology. With the number of treatment options constantly increasing, more frequent monitoring helps the oncologists to respond more quickly in case the treatment is not satisfactory, or a drug resistance is induced. As a result, the patient will receive efficient treatment faster. Cancer medications are often expensive and predicting the effect could be hard, but they can also have the potential to completely cure the cancer. That is why it is important to find the correct medication right as soon as possible. Therefore, screening and constant monitoring for cancer with liquid biopsy is an effective way to improve the quality of cancer treatments and to reduce the burden of cancer. We aim to replace invasive sampling with a less and non-invasive option – liquid biopsy sampling - fully automated.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
LifeOS Genomics Corporation
Taiwan · 1 relevant product
Singlera GENOMICS (SHANGHAI) Ltd.
China · 1 relevant product
Cambrian Bioworks LLC
United States · 2 relevant products
23 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 33 closest product alternatives
LifeOS Genomics Corporation · Taiwan
A multiplex digital PCR platform for liquid biopsy applications offering 0.01% sensitivity assay panels with sample-to-result workflows. The system enables analysis of 100+ targets simultaneously with absolute quantitation capabilities and turnaround times as short as 6 hours.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic system for performing liquid biopsy analyses on biological samples. Integrates DNA methylation technology for non-invasive cancer detection and monitoring.
Cambrian Bioworks LLC · United States
Specialized system for maximizing cell-free DNA yield from plasma samples. Optimized for non-invasive prenatal testing and circulating tumor DNA applications.
30 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products